ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 57 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2018. The put-call ratio across all filers is 3.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,735 | -31.5% | 84,002 | 0.0% | 0.00% | – |
| Q4 2022 | $14,222 | -16.3% | 84,002 | 0.0% | 0.00% | – |
| Q3 2022 | $17,000 | -59.5% | 84,002 | 0.0% | 0.00% | – |
| Q2 2022 | $42,000 | -12.5% | 84,002 | 0.0% | 0.00% | – |
| Q1 2022 | $48,000 | -5.9% | 84,002 | 0.0% | 0.00% | – |
| Q4 2021 | $51,000 | -37.0% | 84,002 | 0.0% | 0.00% | – |
| Q3 2021 | $81,000 | -12.0% | 84,002 | 0.0% | 0.00% | – |
| Q2 2021 | $92,000 | +384.2% | 84,002 | +215.0% | 0.00% | – |
| Q3 2019 | $19,000 | -45.7% | 26,666 | 0.0% | 0.00% | – |
| Q2 2019 | $35,000 | -37.5% | 26,666 | 0.0% | 0.00% | – |
| Q1 2019 | $56,000 | -9.7% | 26,666 | -2.9% | 0.00% | – |
| Q4 2018 | $62,000 | -35.4% | 27,464 | 0.0% | 0.00% | – |
| Q3 2018 | $96,000 | +9.1% | 27,464 | 0.0% | 0.00% | – |
| Q2 2018 | $88,000 | -22.1% | 27,464 | -15.3% | 0.00% | – |
| Q1 2018 | $113,000 | -8.9% | 32,434 | +15.1% | 0.00% | – |
| Q4 2017 | $124,000 | -13.3% | 28,189 | +2.6% | 0.00% | – |
| Q3 2017 | $143,000 | +130.6% | 27,464 | +131.0% | 0.00% | – |
| Q2 2017 | $62,000 | +82.4% | 11,887 | +18.3% | 0.00% | – |
| Q3 2016 | $34,000 | +3.0% | 10,050 | -15.0% | 0.00% | – |
| Q2 2016 | $33,000 | -59.3% | 11,826 | -10.7% | 0.00% | – |
| Q1 2016 | $81,000 | +12.5% | 13,245 | 0.0% | 0.00% | – |
| Q4 2015 | $72,000 | +41.2% | 13,245 | 0.0% | 0.00% | – |
| Q3 2015 | $51,000 | -8.9% | 13,245 | 0.0% | 0.00% | – |
| Q2 2015 | $56,000 | +19.1% | 13,245 | +11.2% | 0.00% | – |
| Q1 2015 | $47,000 | – | 11,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|